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ABSTRACT: Silk continues to amaze: over the past decade, new
research threads have emerged that include the use of silk ﬁbroin
for advanced pharmaceutics, including its suitability for drug
delivery. Despite this ongoing interest, the details of silk ﬁbroin
structures and their subsequent drug interactions at the molecular
level remain elusive, primarily because of the diﬃculties
encountered in modeling the silk ﬁbroin molecule. Here, we
generated an atomistic silk model containing amorphous and
crystalline regions. We then exploited advanced well-tempered
metadynamics simulations to generate molecular conformations
that we subsequently exposed to classical molecular dynamics
simulations to monitor both drug binding and release. Overall, this
study demonstrated the importance of the silk ﬁbroin primary
sequence, electrostatic interactions, hydrogen bonding, and higher-order conformation in the processes of drug binding and
release.
For millennia, humans have used silk thread1 as a suturematerial.2,3 However, the use of the silk ﬁbroin protein for
drug delivery applications, including its use as a nanomedicine
for lysosomotropic drug delivery,4 has only recently been
reported.5,6 The primary and higher-order structures of the silk
ﬁbroin protein are fundamental for its function as a high-tech
ﬁber, but they also dictate the ability of silk ﬁbroin to serve as a
biopolymer for drug delivery.5,6 Clinically relevant therapeutic
agents have been successfully loaded into silk ﬁlms,7,8
hydrogels,9,10 and nanoparticles4,11,12 (reviewed in ref 13),
with an increasing number of studies now speciﬁcally reporting
the use of recombinant silks14 and silk-elastin-like proteins for
anticancer drug delivery (e.g., doxorubicin as a payload).10,12
However, the precise mechanism that controls the interaction
between the payload and silk at the atomic level is not fully
known at present, although seminal studies by Coburn and co-
workers have demonstrated the importance of charge and
crystallinity on drug binding and release.8 Molecular dynamics
simulations are now recognized as a powerful tool for
demonstrating the binding mechanism between a drug (e.g.,
doxorubicin) and several types of drug carrier molecules, such
as nanodiamond,15 graphene oxides,16 and chitosan oligosac-
charide.17 Currently, van der Waals forces, electrostatic
interactions, and hydrogen bonding are suggested as the key
factors that enable doxorubicin binding to a carrier.
Molecular dynamics simulations have been widely used to
investigate the motion of large molecules such as proteins (e.g.,
protein folding and ligand binding at the nanoscale).18,19 For
more than a decade, molecular dynamics simulation has been
used to study silk structures, their mechanical properties,20−22
and the interactions between silk and other molecules (e.g.,
graphene).23 However, many silk structures used previously
were small (e.g., a stack of poly(GA) β-sheets <100 amino
acids long),22,24,25 and the amino acid composition did not
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faithfully reﬂect key components of the silk structure. A key
result of the present study has been the generation and
modeling of silk ﬁbroin fragments totaling 300 amino acids in
length and containing both amorphous (linkers) and
crystalline domains (Figure 1A,B). This fragment is a good
representation of the whole silk structure because the R6.5
subdomain contains the most frequently repeating crystalline
sequences of poly(GA) and GAGAS, ﬂanked by linker 5 and
linker 6 (ref 26); these silk elements have been used by others
and thus provide a useful reference point.23 The use of our 300
amino acid long structure for molecular dynamics simulation is
challenging because of the time scales required for full
exploration of the conformation space and because of the
conformational energy barriers.27 This challenge can be
addressed by using advanced sampling algorithms, such as
well-tempered metadynamics.28,29 The well-tempered metady-
namics method improves the conﬁgurational sampling during
molecular dynamics simulations by adding an external history-
dependent potential, along with selected collective variables
that enable enhanced sampling and reconstruction of free
energy surfaces.29,30 Here, we used well-tempered metady-
namics to explore the conformational free energy proﬁles of
amorphous−crystalline silk structures in water. The collective
variables were the number of β-sheet and α-helix segments,
which are key secondary structure components of silk (see the
Supporting Information for a complete description of the
modeling approaches employed). The simulation provided
realistic three-dimensional amorphous−crystalline silk ﬁbroin
structures, which were then compared to known structures
derived from NMR measurements. The silk structures were
then selected to investigate silk−doxorubicin interactions in
response to pH using classical molecular dynamics simulations.
These data were compared to previously reported experimental
studies.
The critical step for the well-tempered metadynamics
simulations was the selection of the collective variables as
these should be able to distinguish between relevant metastable
states and to describe the key features of the structure.32 Thus,
in this study, the number of β-sheets and α-helix segments
were the collective variables because the secondary structure of
silk contains primarily these two structures. These collective
variables can be detected and tracked to assess the conforma-
tional changes of the silk structure in water along their
trajectories. The convergence of the system was monitored by
reconstructing the time evolution proﬁles of the collective
variables, the Gaussian height, and the free energy landscapes.
At the convergence, three main questions needed to be
considered: Are the collective variable values fully explored
over the simulation time? Does the Gaussian height reach
zero? Are the reconstructed free energy proﬁles similar?29 In
this study, the well-tempered metadynamics simulations of the
silk ﬁbroin structure in water were converged after a 600 ns
simulation because two collective variable values eﬀectively
diﬀused over the simulation (Figure S1A). Speciﬁcally, the
height of the biased potential reached zero (Figure S1B), and
no signiﬁcant change occurred in the free energy surface shape
over the last 50 ns (Figure S2).
Figure 1. Primary structure of the Bombyx mori silk ﬁbroin heavy chain and the amino acid sequences used for molecular dynamics simulations. (A)
Schematic representation of the primary structure of the B. mori silk ﬁbroin heavy chain. R1−R12 represent 12 repeated crystalline domains, and
L1−L11 represent 11 linkers (amorphous regions). The subdomains L5, R6.5, and L6 and the N-terminus (red squares) are used in this study. The
subdomain sequences are available on Uniprot databases in a FASTA ﬁle named P05790 at position number 2281−2323 (L5), 2536−2599 (R6.5),
and 2600−2642 (L6). (B) Schematic representation of the antiparallel silk structures (arrows show the directions) and their amino acid sequences.
(C) Amino acid sequence of the N-terminal domain (available in the Protein Data Bank [3UA0]).31
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Next, the most interesting silk structures were extracted
from the free energy surface at 600 ns, for example, the most
stable structure at the global minimum (Figure 2A point 2), as
well as the relevant structures containing either the highest
number of α-helix segments or the highest number of β-sheet
segments (Figure 2A points 1 and 3, respectively). Silk I*, the
ordered regions of silk I, represents the structure of the silk
solution present in the middle silk gland. It is described as a
type II β-turn structure and is the nucleus for silk II
formation.33 Experimental evidence indicates that 55−58% of
the GAGSGAGA sequence in silk I adopts the Silk I*
structure, while the rest forms a random coil.33 To validate the
simulation, the 14 repetitive GAGSGAGA sequences from the
crystalline domains were extracted from the most stable silk
structure (Figure 2B) and analyzed by (i) plotting the torsion
angles phi and psi on a Ramachandran plot and (ii) examining
the type II β-turn structure patterns (Figure S3).
NMR data have been reported for soluble silk (i.e., silk
stored in the silkworm middle gland Figure S3B), and the
torsion angles of silk structure were plotted (Figure S3A),
adopting a type II β-turn structure model (Figure S3C).34
These literature torsion angles were then compared to the
angles obtained from the silk structure after well-tempered
metadynamics simulations. Here, 38% of the GAGSGAGA
Figure 2. Converged free energy surface of the silk structure in water, showing the key structures and 14 repetitive sequence motifs (GAGSGAGA)
in the crystalline domains of silk ﬁbroin structure. (A) Free energy proﬁle with three relevant silk structures: (1) the silk structure containing the
highest number of α-helix segments, (2) the most stable silk structure at the global minimum, and (3) the silk structure containing the highest
number of β-sheet segments. (B) Fourteen repetitive sequence motifs (GAGSGAGA) extracted from the most stable structure after a 600 ns well-
tempered metadynamics simulation. The number is the residue number for the GAGSGAGA motif in the silk structure. (C) Repetitive sequence
motif GAGSGAGA (at residue numbers 207−214) of the silk structure and its ﬁrst four residues (GAGS) representing a type II β-turn structure
with a hydrogen bond (green dashed line). The silk structures were colored using the Visual Molecular Dynamics software package: α-helix = red,
β-sheet = cyan, turn = green, random-coil = white.
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from the respective sequence was aligned in the area of ideal
torsion angles (red circles) (Figure S3A). All angles of the
GAGSGAGA from residue numbers 207−214 were located
within this area. These data were corroborated by analyzing the
hydrogen bonds and the structural pattern using the Visual
Molecular Dynamics software package.35 This analysis revealed
a type II β-turn structure with one hydrogen bond between the
CO of the glycine (i) and the H−N of the serine (i+3)33
(Figure 2C). Therefore, the silk model described in this study
supports the current Silk I* conformation (i.e., the type II β-
turn structure) previously proposed based on NMR data.34 In
addition, the modeling yielded some residues that formed
unstructured segments not described previously.
Our previous work4,11,36 detailed the manufacture of silk
nanoparticles, which were examined for drug loading and
release, as well as for their capacity for internalization and
traﬃcking in human breast cancer cells. These studies showed
that doxorubicin loading onto silk nanoparticles could be
accomplished by simple adsorption from a doxorubicin
solution. In addition, drug release was pH-dependent, with
Figure 3. Snapshots of doxorubicin distribution on the silk ﬁbroin structure at 0 and 50 ns in the molecular dynamics simulations at the indicated
pH values of 4 and 7.4. The postprocessing analysis of the silk−doxorubicin system is presented as the distribution of the number of doxorubicin
molecules at diﬀerent distances (nm) from silk ﬁbroin structures at 50 ns and the number of hydrogen bonds of all of the silk−doxorubicin systems
over a 50 ns simulation time. The doxorubicin and silk ﬁbroin structures were visualized using the Visual Molecular Dynamics software package; α-
helix = red, β-sheet = cyan, turn = green, random-coil = white, and doxorubicin = red molecules.
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the fastest release occurring at an acidic pH (similar to the
lysosomal pH of approximately 4.5).11,36 Dedicated wet-lab
studies by Coburn and co-workers uncovered the importance
of charge and crystallinity on drug binding and release.8 The
best doxorubicin binding capacity was observed for low-
crystalline silk ﬁbroin, and binding could be further increased
by chemical modiﬁcations of the ﬁbroin. By contrast, drug
release depended on the protonation state of the silk ﬁbroin, so
that the fastest release occurred at a low pH.8 The present in
silico study provides unprecedented atomistic insight into the
mechanism underlying doxorubicin interaction with silk ﬁbroin
and the subsequent eﬀects of pH on drug release. We therefore
used the silk ﬁbroin structures extracted from the well-
tempered metadynamics simulations to study the pH-depend-
ent interaction of doxorubicin with silk. The selected silk
ﬁbroin structures were (i) the most stable silk structure, (ii)
the silk with the highest α-helix content (i.e., Silk I), and (iii)
silk with the highest β-sheet content (i.e., Silk II dominating
silk nanoparticles). The N-terminal domain structure (N-
terminal sequence shown in Figure 1C) was also included
because it contains a pH-responsive region required for silk
self-assembly.31
To mimic the experimental studies, the silk structure models
were subjected to pH 7.4 and 4 (for the experimental
approach, see the SI), which are values that mimic blood
plasma (as well as the loading solution) and the lysosome
interior, respectively. The silk structure models used in this
study contained ﬁve ionizable amino acids. The most
important amino acids were aspartic acid, glutamic acid, and
tyrosine in the amorphous−crystalline domain, whereas the N-
terminal domain contained aspartic acid, glutamic acid,
tyrosine, lysine, and arginine (Figure S4). The pKa of ionizable
residues can be shifted in response to changes in the
surrounding environment (e.g., solvent, pH, etc.), which will
change the protein conformation (e.g., hiding/exposing
ionizable groups in the structure etc.).37 Therefore, the initial
step in the simulation was to calculate the pKa of the ionizable
amino acids in the silk models to allow modiﬁcation of the
protonation states at pH 4 and 7.4 using Discovery Studio
software.
The calculated pKa values for ionizable residues were then
used to estimate the total net charges at pH 4 and 7.4 (Tables
S1−S4). For the amorphous−crystalline domain of the model
silk ﬁbroin structure, the total net charge at pH 4 was less
negative than the charge at pH 7.4 (−2 to −4 at pH 4 and −12
at pH 7.4). By contrast, the N-terminal domain of the silk
ﬁbroin model contained a large number of ionizable amino
acids; therefore, the total net charges of the N-terminal domain
at pH 4 and 7.4 diﬀered signiﬁcantly (+6 at pH 4 and −17 at
pH 7.4) (Table S4). Across all structures, glutamic acid
contributed substantially to the total net charge of all of the silk
ﬁbroin structure models studied here.
The diﬀerences in the total net charges of the silk ﬁbroin
structures can be visualized by generating the distribution of
charged amino acid residues on the surfaces (Figure S5). The
proportion of negatively charged amino acids was higher in the
silk ﬁbroin structure at pH 7.4 than that at pH 4. Extra negative
charges were evident for the amorphous−crystalline silk
structure at pH 7.4 due to the presence of glutamic acid
(residue number 37, 290, 296) and aspartic acid (residue
number 39) (Figure S5A). For the N-terminal domain, the
surface charge distribution at pH 4 and 7.4 was already visually
diﬀerent (Figure S5B) due to the high number of positive
charges at pH 4 (+ 6) and the high number of negative charges
at pH 7.4 (−17) (Table S4).
The model system consisted of modiﬁed protonation states
of the model silk ﬁbroin structure (four separate model
systems), 20 doxorubicin molecules, and water. The molecular
dynamics simulations of all systems were run for 50 ns in
GROMACS packages. We ﬁrst analyzed the spatial distribution
of 20 doxorubicin molecules around the silk ﬁbroin model
structures and speciﬁcally analyzed the doxorubicin position at
the end of the 50 ns run (Figure 3). Overall, the number of
doxorubicin molecules in close proximity to the silk ﬁbroin
model was higher at pH 7.4 than that at pH 4. This indicated
that doxorubicin had a higher binding aﬃnity for silk ﬁbroin at
pH 7.4 than that at an acidic pH. Interestingly, the N-
terminus−doxorubicin system showed a signiﬁcantly higher
number of doxorubicin molecules at a long distance from the
silk structure (>2 nm) at pH 4 than that at the neural pH. This
result suggests that the N-terminal domain is an important
structural element that inﬂuences doxorubicin release.
The intermolecular hydrogen bonds formed between
doxorubicin and each silk ﬁbroin structure model were
calculated because the number of hydrogen bonds between
the drug and the carriers is a key feature that modulates drug
loading, according to previous research.38 The intermolecular
hydrogen bond cutoﬀ distance was set at 0.35 nm with a 30°
cutoﬀ angle.39 Overall, the number of intermolecular hydrogen
bond systems was higher in the pH 7.4 systems than that in the
pH 4 systems, which indicated a high drug loading eﬃcacy at
pH 7.4 (Figure 3). The number of hydrogen bonds between
doxorubicin and the N-terminal domain of silk ﬁbroin was also
substantially higher at pH 7.4 than that at pH 4 (Figure 3).
Therefore, this result proved that the N-terminal domain had a
substantial inﬂuence on the drug loading and drug release
behavior.
The interaction energies were calculated to determine the
binding strength and the types of intermolecular interactions
between doxorubicin and silk ﬁbroin. The three prominent
intermolecular forces can be classiﬁed in the following rank
order: electrostatic interaction > hydrogen bonding > van der
Waals interactions.40 Overall, the total interaction energies
were higher for the pH 7.4 systems than those for the pH 4
systems, indicating a greater doxorubicin−silk interaction at
pH 7.4 (Figure S6). The total energies were also higher in the
crystalline silk structure (Figure S6A) than those in the
amorphous silk structure (Figure S6C), indicating a lower
doxorubicin release from the crystalline structure; this in silico
prediction is in agreement with experimental data sets.7,8
Electrostatic interactions were also important at pH 7.4,
especially for the N-terminal−doxorubicin pair (Figure S6D),
due to the high number of hydrogen bonds (>20) (Figure 3).
Therefore, the electrostatic interaction energy and the number
of hydrogen bonds were plotted to determine the relationship
between these values. The number of hydrogen bonds was
strongly correlated with the electrostatic interaction between
silk ﬁbroin and doxorubicin, and it correlated well with
previous work on doxorubicin−chitosan oligosaccharide
interactions.17 An increasing electrostatic interaction energy
led to a greater number of hydrogen bonds (Figure S7).
LIGPLOT and Discovery Studio were then used to generate
a 2D interaction diagram and to monitor which amino acids of
silk ﬁbroin interacted with doxorubicin at 50 ns. The 2D
diagram of the LIGPLOT detailed hydrogen bonds (green
lines) and hydrophobic interactions (gray arcs) between silk
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ﬁbroin and doxorubicin (Figure S8). The doxorubicin
molecule in LIGPLOT was selected from those that showed
the highest interaction energies with the silk ﬁbroin model at
50 ns. Overall, the number of hydrogen bonds and the number
of amino acids responsible for the silk ﬁbroin doxorubicin
interaction were higher at pH 7.4 than those at pH 4 (Figure
S8 and Table S5). For the silk ﬁbroin structure with the
highest β-sheet content, the interaction between silk and
doxorubicin at pH 4 was dominated by hydrophobic
interactions (Figure S8A), while the interaction at pH 7.4
was dominated by hydrogen bonds. For other silk−
doxorubicin model systems, the two-dimensional diagram
from LIGPLOT did not show signiﬁcant diﬀerences in
response to pH changes.
Overall, pH inﬂuenced the doxorubicin binding aﬃnity
toward silk ﬁbroin because the ionizable amino acid residues
(especially glutamic and aspartic acid) on the ﬁbroin structure
provided a greater number of negative charges at pH 7.4 than
they did at pH 4 (shown in red in Table S5). This correlates
well with previous wet-lab experiments showing pH-dependent
drug release4,7,8,11,36 and indicates that modulation of the
numbers of ionizable groups could be a useful approach for
further reﬁnement of the design of chemically-modiﬁed or
recombinant silks intended for drug delivery.14
In summary, the well-tempered metadynamics simulation
enabled us to explore >1000 amorphous−crystalline silk
ﬁbroin structures and yielded several useful silk conformations,
including both previously reported and novel silk structures
(all of these structures are now freely available to download).
The molecular interaction between these silk ﬁbroin structures
and doxorubicin showed pH-dependent eﬀects. The N-
terminal domain was proven to be an important “switch”
that controls drug binding and release in response to pH. This
pH control was attributed to ionizable amino acid residues,
especially glutamic acid. The electrostatic interactions due to
hydrogen bonds were of critical importance for drug loading
and release. Overall, this study demonstrated important
structure−function relationships that will help in the develop-
ment of recombinant silks with improved drug binding and
release characteristics.
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